Longyi blood glucose test system
Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Jun 24, 2011 – Jun 24, 2016Cancelled- Analysis ID
- 40856a5d717555f06006d0b1f530212a
- Customs Code
- DHY00500330200
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DRAGON PHARMACEUTICAL CO., LTD.
- Intended Use
- This product provides a quantitative blood glucose test, which is suitable for diabetic patients to self-measure blood sugar or medical professionals to measure blood sugar. This system is suitable for fresh microvascular blood for blood glucose detection.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic;; Contract manufacturing
- Registration Date
- Jun 24, 2011
- Expiry Date
- Jun 24, 2016
- Cancellation Date
- Aug 17, 2016
- Status
- Logged out
- Reason
- 許可證已逾有效期
Top companies providing products similar to "Longyi blood glucose test system"
Recently registered similar products
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 40856a5d717555f06006d0b1f530212a and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory, Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.